{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-027585","form_type":"8-K","ticker":"ABBV","cik":"0001551152","company_name":"AbbVie Inc.","filed_at":"2024-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.574616+00:00","generated_at":"2026-06-05T15:08:31.528152+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AbbVie issues $15B in senior notes across 7 tranches to fund acquisitions and repay debt","bullets":["Issued $15.0B aggregate principal of senior notes maturing 2027-2064 with coupons from 4.800% to 5.500%.","Proceeds will prepay $5.0B term loan used for ImmunoGen acquisition and fund pending Cerevel acquisition.","Notes are unsecured, unsubordinated obligations ranking equally with existing unsecured indebtedness.","Underwriters include Morgan Stanley, J.P. Morgan, BofA Securities, and Citigroup."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-027585","json":"https://secwatch.observer/filing/0001104659-24-027585.json","markdown":"https://secwatch.observer/filing/0001104659-24-027585.md","text":"https://secwatch.observer/filing/0001104659-24-027585.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551152/000110465924027585/0001104659-24-027585-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551152/000110465924027585/tm246405d5_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T15:08:31.528152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}